Clinical Trials
All Clinical Trials - Page 42 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT01602913N/ACompleted
Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
Liraglutide
- NCT01654120Phase 4Completed
Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics
Liraglutide
- NCT01507038Phase 2Completed
Safety and Efficacy of YH14617 in Diabetes Mellitus
Exenatide
- NCT01501084Phase 1Completed
Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women
Exenatide
- NCT01452451Phase 2Completed
Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Exenatide
- NCT01392573Phase 3Completed
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes
Liraglutide
- NCT01484262N/ACompleted
Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2
Liraglutide
- NCT01516476Phase 2Terminated
Study of RO6807952 in Patients With Diabetes Mellitus Type 2
Liraglutide
- NCT01911468Phase 4Completed
Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin
Liraglutide
- NCT01899430Phase 4Completed
Polycystic Ovary Syndrome and Liraglutide
Liraglutide
- NCT01472640N/ACompleted
The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus
Liraglutide
- NCT01468181Phase 3Completed
A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
Dulaglutide
- NCT01363609N/ACompleted
Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes
Liraglutide
- NCT01455441Phase 4Completed
The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes
Liraglutide
- NCT01473953Phase 1Completed
Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects
Liraglutide
- NCT01460069N/ACompleted
The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis
Liraglutide
- NCT01458210Phase 1Completed
A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants
Dulaglutide
- NCT01473147N/ACompleted
Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients
Exenatide
- NCT01345734N/ACompleted
Non-Interventional Study on Safety of Liraglutide in Subjects With Type 2 Diabetes
Liraglutide
- NCT01388920Phase 2Terminated
Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting
Tesamorelin
- NCT01382589Phase 2Completed
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo
Afamelanotide
- NCT01438073Phase 1Completed
Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling
Kisspeptin
- NCT01431391Phase 2Completed
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Gonadorelin
- NCT01368263Phase 2Terminated
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
Gonadorelin
- NCT01419197Phase 3Completed
A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy
Gonadorelin
- NCT01388361Phase 3Completed
Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin
Liraglutide
- NCT01394341Phase 4Completed
Liraglutide Treatment to Patients With Severe Renal Insufficiency
Liraglutide
- NCT01432938Phase 1Completed
A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants
Dulaglutide
- NCT01436201Phase 1Completed
A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants
Dulaglutide
- NCT01281228N/ACompleted
The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
Exenatide
- NCT01514149Phase 2Terminated
Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy
Exenatide
- NCT01234649Phase 3Completed
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
Liraglutide
- NCT01387347Phase 2Completed
Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye
TB-500
- NCT02646189Phase 1/Phase 2Completed
Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients
Thymosin-Alpha-1
- NCT01419353Phase 4Completed
Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol
Gonadorelin
- NCT01451905N/AUnknown
GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis
Liraglutide
- NCT01408888Phase 1Completed
A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes
Dulaglutide
- NCT01394952Phase 3Completed
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Dulaglutide
- NCT01403025N/ACompleted
Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes
Liraglutide
- NCT04341324N/ACompleted
Effect of ADT in Chinese Male With Prostate Cancer
Gonadorelin
- NCT04578496Phase 3Completed
A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP)
Afamelanotide
- NCT01372995Phase 2Completed
Vitamin D in Ventilated ICU Patients
Ll-37
- NCT01398280EARLY_Phase 1Completed
Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation
Ll-37
- NCT01343368Phase 2Terminated
Preservation of Ovarian Function After Hematopoietic Cell Transplant
Gonadorelin
- NCT01272232Phase 3Completed
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Liraglutide
- NCT01272219Phase 3Completed
Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes
Liraglutide
- NCT01382719Phase 2Completed
Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder
PT-141
- NCT01430195Phase 1Completed
Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)
Afamelanotide
- NCT01403038Phase 1Completed
An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females
Gonadorelin
- NCT01326312Phase 2Terminated
Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer
Gonadorelin